Aledade announces C-suite shakeup, SyncThink's new clinical advisory board and other digital health hires

Also: CherryCircle names new board member; higi taps new consultant.
By Dave Muoio and Laura Lovett
03:23 pm
Aledade, a health tech startup that partners with providers to build primary care-focused ACOs, announced a trio of C-suite personnel changes. Among these is news that cofounder Edwin Miller has left his previous role as chief technology officer to become the company’s chief product officer. Replacing him is athenahealth alumnus Brady Richards, while Dr. Emily Maxson is slated to become the company’s first chief medical officer.
“Aledade’s success would not be possible without the insight and expertise of those in our executive team, who are some of the best minds in primary care, technology and data analytics,” Dr. Farzad Mostashari, cofounder and CEO of Aledade, said in a statement. “Under Edwin, Brady, and Dr. Maxson’s leadership, we will continue to bring our unique, value-based care model to independent physicians and their patients across the country.”
Health kiosk maker higi has tapped consultant Darren Singer take on the new position of group VP of network alliances. Singer will be working to expand the company’s consumer engagement programs for retail pharmacy partners.
“We are thrilled to have Darren join higi as a member of our executive team,” Jeff Bennett, higi CEO, said in a statement. “He brings an incredible history of connecting consumers to care — on both the brand partnerships side of the house and as a leader in retail pharmacy — and will play a pivotal role in delivering strategic value to our partners and clients.”

SyncThink, a Palo Alto-based startup applying VR and eye-tracking to assess ability to focus as an indicator of concussion damage, announced a new clinical advisory board. The new members include Dr. Jeffrey KutcherDr. Kristen SteenersonDr. Leonore HergetDr. Marie Boo and Dr. Gordon Matheson

These new members come from a variety of backgrounds including neurology, sport sciences and even the US Ski and Snowboard team. The board will be focused on providing expert feedback and gathering user feedback. 

“We are thrilled to be working with these experts who bring decades of clinical research and evidence-based practice to the SyncThink team that will help us further the mission of developing a robust, multi-functional platform that services the needs of many healthcare professionals,” Laura Yecies, CEO of SyncThink, said in a statement. 


This morning venture investing fund Flare Capital tapped Parth Desai to join as its new senior associate. 

Desai comes to the firm after working with New York Presbyterian’s investment team. Previously he worked for Deloitte Consulting and the Massachusetts House of Representatives. He comes to the role with a Masters of Arts in Clinical Medicine and a Masters of Public Health in Health Management and Policy from Boston University. 

In mid-March CherryCircle, a software company focused on accelerating pharmaceutical manufacturing process development, announced that Emma Cartmell will be joining its board. 

Cartmell is an angel investor focusing on affordable high impact products. She also serves on several boards including HIMSS North America, Austin Healthcare council and Morgan Stanley Equity Expansion fund. 

“CherryCircle’s QbDVision solution is the type of innovation the pharmaceutical industry needs,” Cartmell said in a statement. “I believe in their vision to reduce the amount of time and expense it takes to bring drugs and medical devices to market and this team has the experience to make it happen.”


The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!